1-2 of 2
Eleonora Vismara, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.

Alessandra Tedeschi, MD, Davide Rossi, MD, Marta Coscia, MD, PhD, Eleonora Vismara, MD, Valeria Belsito Petrizzi, MD, Ester Orlandi, Nicola Cascavilla, Lydia Scarfò, MD, Marina Motta, MD, Candida Vitale, MD, Francesca Ricci, MD, Lorenzo De Paoli, MD, Alfonso Maria D'Arco, MD, Andrea Gallamini, MD, Gianluca Gaidano, MD, PhD, Enrica Morra, MD, Massimo Massaia, MD, Marco Montillo, MD
Journal: Blood
Blood (2012) 120 (21): 2898.
https://doi.org/10.1182/blood.V120.21.2898.2898
Published: 2012
Journal Articles

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Eleonora Vismara, MD, Denis Ciapanna, MD, Valeria Belsito Petrizzi, MD, Monica Crugnola, MD, Mauro Spriano, MD, Lilj Uziel, MD, Angelo De Blasio, MD, Pierangelo Spedini, PhD, Enrica Morra, MD
Journal: Blood
Blood (2007) 110 (11): 3133.
https://doi.org/10.1182/blood.V110.11.3133.3133
Published: 2007